EDG7

Jump to navigation Jump to search



Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
Identifiers
Symbols EDG7 ; GPCR; Edg-7; HOFNH30; LP-A3; LPA3; LPAR3; RP4-678I3
External IDs Template:OMIM5 Template:MGI HomoloGene8123
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7, also known as EDG7, is a human gene.[1]

This gene encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. This protein functions as a cellular receptor for lysophosphatidic acid and mediates lysophosphatidic acid-evoked calcium mobilization. This receptor couples predominantly to G(q/11) alpha proteins.[1]

See also

References

  1. 1.0 1.1 "Entrez Gene: EDG7 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7".

Further reading

  • Contos JJ, Ishii I, Chun J (2001). "Lysophosphatidic acid receptors". Mol. Pharmacol. 58 (6): 1188–96. PMID 11093753.
  • Bandoh K, Aoki J, Hosono H; et al. (1999). "Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid". J. Biol. Chem. 274 (39): 27776–85. PMID 10488122.
  • Im DS, Heise CE, Harding MA; et al. (2000). "Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate". Mol. Pharmacol. 57 (4): 753–9. PMID 10727522.
  • Fitzgerald LR, Dytko GM, Sarau HM; et al. (2000). "Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid". Biochem. Biophys. Res. Commun. 273 (3): 805–10. doi:10.1006/bbrc.2000.2943. PMID 10891327.
  • Tokumura A, Sinomiya J, Kishimoto S; et al. (2002). "Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids". Biochem. J. 365 (Pt 3): 617–28. doi:10.1042/BJ20020348. PMID 11982483.
  • Hama K, Bandoh K, Kakehi Y; et al. (2002). "Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors". FEBS Lett. 523 (1–3): 187–92. PMID 12123830.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Cremers B, Flesch M, Kostenis E; et al. (2003). "Modulation of myocardial contractility by lysophosphatidic acid (LPA)". J. Mol. Cell. Cardiol. 35 (1): 71–80. PMID 12623301.
  • Fujita T, Miyamoto S, Onoyama I; et al. (2003). "Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer". Cancer Lett. 192 (2): 161–9. PMID 12668280.
  • Jin Y, Knudsen E, Wang L, Maghazachi AA (2003). "Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization". Eur. J. Immunol. 33 (8): 2083–9. doi:10.1002/eji.200323711. PMID 12884281.
  • Xing Y, Ganji SH, Noh JW, Kamanna VS (2005). "Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth". Am. J. Physiol. Renal Physiol. 287 (6): F1250–7. doi:10.1152/ajprenal.00342.2003. PMID 15292052.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Template:WH Template:WS